Literature DB >> 17882910

Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis.

Marcelo B Antunes1, Michael D Feldman, Noam A Cohen, Alexander G Chiu.   

Abstract

BACKGROUND: Topical antimicrobials are commonly used to treat Pseudomonas sinusitis after endoscopic sinus surgery. Despite their popularity, there is limited data in the literature to support its use. This study is the first to examine the effects of topical tobramycin in an animal model of Pseudomonas sinusitis.
METHODS: Pseudomonas aeruginosa sinusitis was induced in the maxillary sinus of New Zealand white rabbits. Study groups received various concentrations of topical tobramycin instilled through a single lumen catheter embedded within the maxillary sinus for 7 consecutive days. A control group received normal saline irrigation. Bacterial counts were measured from the nasal lavage after irrigation. The sinonasal complex was analyzed and a histological grading system was used to score the degree of infection at study end.
RESULTS: Nasal lavage bacterial counts of the saline control group remained persistently elevated throughout the study. Introduction of increasing concentrations of topical tobramycin caused the bacterial counts to fall to zero by study end. There was a dose-dependent histological response in which increasing concentrations of tobramycin led to a marked reduction but not total elimination of inflammation within the mucosa and underlying bone.
CONCLUSION: As opposed to normal saline irrigations, topical tobramycin led to a significant improvement in the degree of infection within an animal model of P. aeruginosa sinusitis. Despite the elimination of bacteria within the nasal lavage, there was a suggestion of a residual indolent infection as evidenced by persistent inflammation within the mucosa and underlying bone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882910     DOI: 10.2500/ajr.2007.21.3046

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  11 in total

1.  Comment on: Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis.

Authors:  Satvinder Singh Bakshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-04       Impact factor: 2.503

2.  Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model.

Authors:  Do-Yeon Cho; Kyle Hoffman; Daniel Skinner; Calvin Mackey; Dong Jin Lim; Grant C Alexander; Chae Yun Bae; Dong Keun Han; Ho-Wook Jun; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2016-12-19       Impact factor: 3.858

3.  The significance of osteitis in rhinosinusitis.

Authors:  Neeraj Sethi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-27       Impact factor: 2.503

Review 4.  Surfactants in the management of rhinopathologies.

Authors:  Philip L Rosen; James N Palmer; Bert W O'Malley; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

5.  Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly.

Authors:  Joshua L Kennedy; Larry Borish
Journal:  Am J Rhinol Allergy       Date:  2013 Nov-Dec       Impact factor: 2.467

6.  The role of topical therapies in the treatment of chronic rhinosinusitis.

Authors:  Jeffrey D Suh; Vijay Ramakrishnan; Alexander G Chiu
Journal:  Braz J Otorhinolaryngol       Date:  2011 Nov-Dec

Review 7.  Impact of Bacterial Infections on Osteogenesis: Evidence From In Vivo Studies.

Authors:  Michiel Croes; Bart C H van der Wal; H Charles Vogely
Journal:  J Orthop Res       Date:  2019-08-11       Impact factor: 3.494

8.  Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model.

Authors:  Roza Khalmuratova; Mingyu Lee; Jong Wan Park; Hyun Woo Shin
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

9.  D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells.

Authors:  Saharut Wongkaewkhiaw; Suwimol Taweechaisupapong; Sanguansak Thanaviratananich; Jan G M Bolscher; Kamran Nazmi; Chitchanok Anutrakunchai; Sorujsiri Chareonsudjai; Sakawrat Kanthawong
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

Review 10.  Novel drug-delivery systems for patients with chronic rhinosinusitis.

Authors:  Silviu Albu
Journal:  Drug Des Devel Ther       Date:  2012-05-31       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.